Free Trial

HB Wealth Management LLC Boosts Stake in Haleon PLC Sponsored ADR (NYSE:HLN)

Haleon logo with Medical background

Key Points

  • HB Wealth Management LLC increased its stake in Haleon PLC by 42.2% in the first quarter, owning 91,594 shares valued at $943,000.
  • Several institutional investors have also made significant changes to their positions in Haleon, including Wellington Management Group LLP, which grew its stake by 67.5%.
  • Despite recent upgrades from analysts, Haleon's stock has decreased by 1.6%, trading at $9.65 with a market cap of $43.35 billion.
  • Five stocks to consider instead of Haleon.

HB Wealth Management LLC increased its holdings in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 42.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 91,594 shares of the company's stock after purchasing an additional 27,192 shares during the quarter. HB Wealth Management LLC's holdings in Haleon were worth $943,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of HLN. Farther Finance Advisors LLC raised its holdings in shares of Haleon by 8.8% during the first quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock valued at $131,000 after purchasing an additional 1,041 shares during the period. Apollon Wealth Management LLC raised its holdings in shares of Haleon by 5.4% in the 1st quarter. Apollon Wealth Management LLC now owns 21,722 shares of the company's stock worth $224,000 after acquiring an additional 1,111 shares during the last quarter. Simplicity Wealth LLC lifted its position in Haleon by 7.9% in the 1st quarter. Simplicity Wealth LLC now owns 15,482 shares of the company's stock valued at $159,000 after acquiring an additional 1,135 shares in the last quarter. Holistic Financial Partners boosted its stake in Haleon by 9.6% during the 1st quarter. Holistic Financial Partners now owns 13,379 shares of the company's stock valued at $138,000 after purchasing an additional 1,172 shares during the last quarter. Finally, AE Wealth Management LLC increased its holdings in Haleon by 6.5% during the 1st quarter. AE Wealth Management LLC now owns 19,323 shares of the company's stock worth $199,000 after purchasing an additional 1,186 shares in the last quarter. Institutional investors own 6.67% of the company's stock.

Haleon Price Performance

Shares of Haleon stock traded up $0.24 during trading hours on Friday, reaching $9.67. The company's stock had a trading volume of 16,930,452 shares, compared to its average volume of 13,335,736. The firm has a 50 day moving average price of $10.40 and a 200-day moving average price of $10.18. Haleon PLC Sponsored ADR has a one year low of $8.86 and a one year high of $11.42. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.98 and a quick ratio of 0.78. The stock has a market cap of $43.44 billion, a P/E ratio of 24.80, a P/E/G ratio of 2.79 and a beta of 0.25.

Analysts Set New Price Targets

HLN has been the subject of a number of recent analyst reports. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective for the company in a research report on Tuesday, May 27th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective for the company in a research report on Friday, May 9th. Barclays reissued an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Finally, Wall Street Zen downgraded shares of Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Six investment analysts have rated the stock with a hold rating, four have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Haleon presently has a consensus rating of "Moderate Buy" and an average target price of $12.33.

Read Our Latest Analysis on HLN

Haleon Company Profile

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Featured Stories

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Should You Invest $1,000 in Haleon Right Now?

Before you consider Haleon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.

While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines